Leerink sees constructive outcomes for Kymera Therapeutics in J&J-Kaken deal
https://www.tipranks.com/information/the-fly/leerink-sees-positive-readthrough-for-kymera-therapeutics-from-jj-kaken-deal Leerink maintains an outperform ranking and $60 value goal on Kymera…
